Commercializing a breakthrough advance in inflammation science. MORE
Antibe Therapeutics is a publicly traded biotechnology company exploiting groundbreaking advances in inflammation science.
Antibe Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference
Antibe Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference